Exane Derivatives’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,880
Closed -$352K 794
2022
Q1
$352K Sell
1,880
-2,101
-53% -$379K 0.1% 229
2021
Q4
$651K Buy
3,981
+6
+0.2% +$1.02K 0.16% 145
2021
Q3
$666K Sell
3,975
-317
-7% -$53K 0.16% 137
2021
Q2
$741K Buy
+4,292
New +$672K 0.17% 119
2021
Q1
Sell
-4,415
Closed -$534K 914
2020
Q4
$534K Sell
4,415
-70
-2% -$7.75K 0.16% 143
2020
Q3
$450K Sell
4,485
-3,581
-44% -$352K 0.13% 143
2020
Q2
$768K Sell
8,066
-770
-9% -$70.9K 0.21% 101
2020
Q1
$756K Buy
8,836
+2,256
+34% +$262K 0.21% 94
2019
Q4
$854K Sell
6,580
-3,202
-33% -$383K 0.16% 108
2019
Q3
$1.16M Buy
9,782
+588
+6% +$72.1K 0.21% 97
2019
Q2
$1.13M Buy
+9,194
New +$1.08M 0.2% 99
2019
Q1
Sell
-7,027
Closed -$670K 664
2018
Q4
$670K Sell
7,027
-1,074
-13% -$112K 0.12% 150
2018
Q3
$862K Buy
8,101
+2,295
+40% +$239K 0.16% 119
2018
Q2
$569K Hold
5,806
0.09% 167
2018
Q1
$535K Sell
5,806
-1,834
-24% -$178K 0.11% 165
2017
Q4
$758K Sell
7,640
-4,104
-35% -$391K 0.13% 133
2017
Q3
$1.06M Buy
11,744
+819
+7% +$70.4K 0.2% 82
2017
Q2
$920K Sell
10,925
-6,431
-37% -$509K 0.2% 95
2017
Q1
$1.37M Sell
17,356
-5,596
-24% -$437K 0.31% 79
2016
Q4
$1.7M Buy
22,952
+2,149
+10% +$149K 0.34% 64
2016
Q3
$1.33M Buy
20,803
+6,556
+46% +$421K 0.2% 84
2016
Q2
$866K Sell
14,247
-415
-3% -$26.3K 0.14% 93
2016
Q1
$900K Buy
+14,662
New +$853K 0.12% 97
2015
Q4
Sell
-23,253
Closed -$1.72M 519
2015
Q3
$1.72M Buy
23,253
+9,128
+65% +$702K 0.22% 71
2015
Q2
$1.1M Sell
14,125
-11,359
-45% -$901K 0.12% 86
2015
Q1
$1.99M Buy
25,484
+23,983
+1,598% +$1.99M 0.22% 62
2014
Q4
$140K Buy
+1,501
New +$135K 0.02% 252

Other funds holding AXP

Exane Derivatives's AXP Position: Q2 2022 in Review

Exane Derivatives sold out of American Express (AXP) in Q2 2022, closing a stake of 1,880 shares — an estimated $352K sold.

Exane Derivatives first reported a position in AXP in Q4 2014 and held it in 27 quarters. The position peaked at $1.99M in Q1 2015. 1,970 funds tracked by Wall St. Rank hold AXP as of Q2 2022.

  • Exane Derivatives reported no remaining American Express position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,880 American Express shares in Q2 2022, an estimated $352K.
  • Exane Derivatives first reported a position in American Express in Q4 2014 and held it in 27 quarters.
  • Exane Derivatives's American Express position peaked at $1.99M in Q1 2015.
  • 1,970 funds tracked by Wall St. Rank held American Express as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.